6,000 Boys Aged 17-18 to Get HPV Vaccine
Cantabria Launches HPV Vaccination Campaign for Teen Boys
Table of Contents
Health officials in Cantabria, Spain, are launching a targeted campaign to vaccinate approximately 6,000 boys aged 17 and 18 against the human papillomavirus (HPV). This initiative, scheduled for May, is part of a broader effort to protect adolescents who were not covered when the vaccine was introduced into the official calendar in 2023.
The campaign aims to address the prevalence of HPV, the most common sexually transmitted infection and a leading cause of cervical cancer in women and other cancers in men. The operation, dubbed ‘Repesca,’ will focus on adolescents who were not vaccinated when the program was first implemented.
“In front of the human papillomavirus (HPV), the most frequent sexually transmitted infection and the main cause of the cervical cancer (cervix) in women and other cancer injuries in men. It will be the first part of the operation ‘Repesca’ of all adolescents who were out of coverage when the vaccine for men in the official calendar was introduced, in 2023.”
In the United States, the HPV vaccine has been a cornerstone of public health initiatives. According to the Centers for Disease Control and Prevention (CDC), the HPV vaccine is recommended for boys and girls aged 11 or 12 years, and can be given through age 26. The vaccine has been shown to significantly reduce the risk of HPV-related cancers, including cervical, anal, and oropharyngeal cancers.
The campaign in Cantabria will initially target boys aged 17 and 18, who will receive SMS messages to their mobile phones, directing them to their respective health centers. Luis Viloria, head of the public health service, emphasized the importance of updating phone numbers associated with health cards, as many may still be linked to parental numbers.
The vaccine distribution is expected to begin the week of May 5 to 9. Viloria stated, “By then, we will have distributed in the health centers the extra quantity of sufficient vaccine to develop this campaign.” Specifically, 6,000 doses will be available, matching the estimated number of young people in the 17 and 18 age group. For younger adolescents, aged 13 to 16, the vaccine will be offered during routine primary care consultations.
Boys who have already received the vaccine privately will not need to be immunized again. The total population covered by this ‘rescue’ operation will include 18,000 young Cantabrians aged 13 to 18.
In Spain, approximately 2,000 new cases of cervical cancer are diagnosed annually, with about 700 deaths recorded. In Cantabria, ten women died from cervical cancer in 2022. While prevention campaigns have traditionally focused on the female population, the recommendation to expand to men is timely due to their role as transmitters and the virus’s responsibility for various cancers, including anogenital cancers and other types of warts, such as those on the penis, anus, or throat, diagnosed in both sexes.
In the United States, the HPV vaccine has been widely adopted, with high vaccination rates among adolescents. According to the CDC, the HPV vaccine has been shown to reduce the risk of cervical cancer by 90%. However, compliance with the full vaccination schedule remains a challenge, with only about 54% of adolescents completing the recommended series.
Critics argue that the focus on adolescent boys may divert resources from other critical health initiatives. However, public health experts emphasize that vaccinating boys is essential for herd immunity and reducing the overall prevalence of HPV. The CDC recommends that all adolescents receive the HPV vaccine to protect against a range of cancers and other health issues.
Recent studies have shown that HPV-related cancers are on the rise in the United States, particularly among men. According to the American Cancer Society, the incidence of HPV-related oropharyngeal cancers has increased by 225% in the past three decades. This trend underscores the importance of comprehensive vaccination programs that include both boys and girls.
In conclusion, the HPV vaccination campaign in Cantabria serves as a model for other regions, highlighting the importance of comprehensive public health initiatives. As the United States continues to grapple with the rising incidence of HPV-related cancers, similar campaigns could play a crucial role in protecting public health and reducing the burden of disease.
The campaign in Cantabria is a proactive step towards ensuring that all adolescents are protected against HPV, a virus that can have devastating health consequences. By targeting both boys and girls, the initiative aims to create a safer and healthier future for the next generation.
For more information on HPV vaccination and public health initiatives, visit the CDC’s HPV website.
HPV Vaccination Campaign in Cantabria: A Q&A Overview
What is HPV and Why is vaccination Critically important?
Q: What is the human papillomavirus (HPV), and why are vaccines important?
A: Human Papillomavirus (HPV) is the most common sexually transmitted infection worldwide. It is indeed known to be a primary cause of cervical cancer in women and a contributing factor to various other cancers in both women and men, such as anal, oropharyngeal, and penile cancers. Vaccination against HPV is crucial as it significantly reduces the risk of HPV-related cancers and diseases, continuing to be an essential element in public health initiatives globally. For instance,the HPV vaccine has been shown to reduce the risk of cervical cancer by 90% [2].
Details of the Cantabria Vaccination Campaign
Q: What is the aim of the HPV vaccination campaign in Cantabria?
A: The campaign, launched in Cantabria, Spain, aims to vaccinate approximately 6,000 boys aged 17 and 18 against HPV. This effort is part of a broader ‘Repesca’ operation targeting adolescents who were not covered by the program when it was first introduced in 2023.The initiative aims to combat the prevalence of HPV, improve public health by lowering the incidence of related cancers, and protect individuals by addressing the spread of HPV that occurs through sexual contact.
Q: How is the Cantabria campaign targeting the adolescent population?
A: Health officials will begin by focusing on boys aged 17 and 18, who will receive SMS messages to guide them to their health centers. For efficient management,teenagers between 13 to 16 will receive the vaccine during routine primary care. The health service is ensuring that the right number of vaccines is available to cover the estimated target population. To support this initiative, Luis Viloria stressed the importance of updating mobile numbers associated with health cards [1].
Q: What countries are conducting similar vaccination campaigns?
A: Besides Spain, countries like the United States have well-established HPV vaccination programs, with the Centers for disease Control and Prevention (CDC) recommending the vaccine for adolescents aged 11 or 12, extendable to age 26. These programs focus on both boys and girls to establish herd immunity and reduce HPV prevalence significantly [2].
Impact and Importance of Vaccination
Q: Why is it essential to include boys in the HPV vaccination campaign?
A: Including boys in the vaccination efforts is vital not only to protect them from potential HPV-related health issues but also to curb the virus’s transmission. Boys can act as carriers of HPV, spreading it to sexual partners and contributing to its prevalence. By vaccinating both sexes, public health experts aim to reduce overall HPV-related diseases and cancers, embracing a complete approach to eradication.
Q: What are the challenges in completing the full HPV vaccination schedule?
A: Despite high initial uptake rates,a significant challenge remains in ensuring adolescents complete the entire recommended vaccination series. In the U.S.,only about 54% complete the full series. addressing this gap is crucial for maximizing the vaccine’s protective effects across the population [3].
health Outcomes and Public Health Implications
Q: What are the statistics on HPV-related diseases in Spain and other regions?
A: In Spain,around 2,000 new cases of cervical cancer are diagnosed annually,with about 700 deaths. In Cantabria, ten women died from cervical cancer in 2022.Alarmingly, HPV-related oropharyngeal cancers have increased by 225% in the U.S. over the past three decades, emphasizing the need for widespread vaccination programs.These statistics underline the critical public health implications of HPV and the benefits of vaccination strategies like the one in Cantabria [2].
Conclusion and Further Data
Q: What can be concluded about HPV vaccination from the Cantabria campaign?
A: The Cantabria campaign underscores the importance of comprehensive public health initiatives targeting HPV. By vaccinating both boys and girls, regions can protect future generations from a virus that poses significant health risks. Such campaigns serve as models for other regions aiming to reduce the burden of HPV-related diseases and protect public health on a broader scale.
For more detailed information on HPV vaccination and ongoing public health initiatives, consider visiting the CDC’s HPV website.